20
Concord Biotech Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MUPIROCIN CALCIUM USP, with a corresponding US DMF Number 28907.
Remarkably, this DMF maintains an Active status since its submission on January 07, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 03, 2015, and payment made on January 07, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II